No trials match your search ""

• Magnetic Resonance Imaging of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Intraoperative Detection of Residual Cancer in Breast Cancer

  Stanford is currently accepting patients for this trial.

• Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

  Stanford is currently accepting patients for this trial.

• The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

  Stanford is currently accepting patients for this trial.

• Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer

  Stanford is currently accepting patients for this trial.

• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC)

  Stanford is currently accepting patients for this trial.

• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

  Stanford is currently accepting patients for this trial.

• Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, MBC (CONTESSA)

  Stanford is currently accepting patients for this trial.

• Molecular and Cellular Analysis of Breast Cancer

  Stanford is currently accepting patients for this trial.

• Safety Study of MGD009 in B7-H3-expressing Tumors

  Stanford is currently accepting patients for this trial.

• Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

  Stanford is currently accepting patients for this trial.

• Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA

  Stanford is currently accepting patients for this trial.

• Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

  Stanford is currently accepting patients for this trial.

• Phase II Talazoparib in BRCA1 +BRCA2 Wild-Type &Triple-Neg /HER2-Negative Breast Cancer /SolidTumors

  Stanford is currently accepting patients for this trial.

• Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer

  Stanford is currently accepting patients for this trial.

• National Breast Cancer and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

No trials match your search ""

• National Breast Cancer and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• International Lymphatic Disease and Lymphedema Registry

  Stanford is currently accepting patients for this trial.

• Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

  Stanford is currently accepting patients for this trial.

• A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

  Stanford is currently accepting patients for this trial.

• Assessment of Patient Experience During Treatment for Cancer

  Stanford is currently accepting patients for this trial.

• A Study of IMO-2125 in Combination With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)

  Stanford is currently accepting patients for this trial.

• PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

  Stanford is currently accepting patients for this trial.

• Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

  Stanford is currently accepting patients for this trial.

• Pembrolizumab and Interferon Gamma-1b in Treating Patients With Stage IB-IVB Relapsed or Refractory Mycosis Fungoides and Sezary Syndrome

  Stanford is currently accepting patients for this trial.

• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors

  Stanford is currently accepting patients for this trial.

• A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma

  Stanford is currently accepting patients for this trial.

• Safety Study of MGD009 in B7-H3-expressing Tumors

  Stanford is currently accepting patients for this trial.

• Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds

  Stanford is currently accepting patients for this trial.

• Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

  Stanford is currently accepting patients for this trial.

• Detection of Immune Changes as a Result of Surgical Trauma in Human Subject

  Stanford is currently accepting patients for this trial.